Risk of second primary cancer in patients with head and neck squamous cell carcinoma: a systemic review and meta-analysis.
Head and neck squamous cell carcinoma
Meta-analysis
Person-year incidence
Risk factors
Second primary cancer
Journal
Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
06
06
2022
accepted:
07
05
2023
medline:
11
9
2023
pubmed:
4
8
2023
entrez:
4
8
2023
Statut:
ppublish
Résumé
Second primary cancer is a common event in patients with head and neck squamous cell carcinoma. However, the incidence and relevant factors vary by studies. We conducted a systematic review and meta-analysis of observational studies to estimate the incidence and relevant risk factors. PubMed and Web of Science were searched for studies published between January 2000 and December 2020 that reported the incidence of SPC in HNSCC patients. Per 1000-person-year incidence and odds ratios were used to estimate the incidence and potential risk factors. Due to the high heterogeneity, random-effects models were used to estimate the incidence and 95% confidence interval. Seven thousand seven hundred thirteen articles were identified from the databases, in which 60 studies were included in this meta-analysis. The pooled incidence of the total, synchronous, and metachronous SPC in patients with HNSCC were 29.116 per 1000-person-year, 6.960 per 1000-person-year, and 26.025 per 1000-person-year, respectively. The head and neck region was the most common area where SPC occurred, followed by the lung (7.472 per 1000-person-year) and upper digestive tract (2.696 per 1000-person-year). Smoking, alcohol consumption, betel quid chewing, primary cancer of T SPC is frequently observed in HNSCC patients and had great impact on the prognosis. The findings could promote a more individualized follow-up strategy for SPC in HNSCC patients. This systemic review and meta-analysis provide sufficient evidence for the establishment of the follow-up strategy for head and neck squamous cancer patients.
Identifiants
pubmed: 37540282
doi: 10.1007/s00784-023-05066-3
pii: 10.1007/s00784-023-05066-3
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Pagination
4897-4910Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Sung H, Hyun N, Leach CR et al (2020) Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States. JAMA 324(24):2521–2535. https://doi.org/10.1001/jama.2020.23130
doi: 10.1001/jama.2020.23130
pubmed: 33351041
pmcid: 7756242
Baxi SS, Pinheiro LC, Patil SM et al (2014) Causes of death in long-term survivors of head and neck cancer. Cancer 120(10):1507–1513. https://doi.org/10.1002/cncr.28588
doi: 10.1002/cncr.28588
pubmed: 24863390
Simpson MC, Massa ST, Boakye EA et al (2018) Primary cancer vs competing causes of death in survivors of head and neck cancer. JAMA Oncol 4(2):257–259. https://doi.org/10.1001/jamaoncol.2017.4478
doi: 10.1001/jamaoncol.2017.4478
pubmed: 29285537
van der Schroeff MP, van de Schans SA, Piccirillo JF et al (2010) Conditional relative survival in head and neck squamous cell carcinoma: permanent excess mortality risk for long-term survivors. Head Neck 32(12):1613–1618. https://doi.org/10.1002/hed.21369
doi: 10.1002/hed.21369
pubmed: 20310043
Collins C, Frese T, Merode TV et al (2020) General practice and the community: research on health service, quality improvements and training. Selected abstracts from the EGPRN Meeting in Vigo, Spain, 17–20 October 2019. Eur J Gen Pract 26(1):42–50. https://doi.org/10.1080/13814788.2020.1719994
doi: 10.1080/13814788.2020.1719994
Travis LB, Demark Wahnefried W, Allan JM et al (2013) Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol 10(5):289–301. https://doi.org/10.1038/nrclinonc.2013.41
doi: 10.1038/nrclinonc.2013.41
pubmed: 23529000
Berrington de Gonzalez A, Kutsenko A, Rajaraman P (2012) Sarcoma risk after radiation exposure. Clin Sarcoma Res 2(1):18. https://doi.org/10.1186/2045-3329-2-18
doi: 10.1186/2045-3329-2-18
pubmed: 23036235
pmcid: 3507855
Cohen EEW, LaMonte SJ, Erb NL et al (2016) American Cancer Society head and neck cancer survivorship care guideline. CA: Cancer J Clin 66(3):203–239. https://doi.org/10.3322/caac.21343
doi: 10.3322/caac.21343
pubmed: 27002678
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372:n71. https://doi.org/10.1136/bmj.n71
doi: 10.1136/bmj.n71
pubmed: 33782057
pmcid: 8005924
Supramaniam R (2008) New malignancies among cancer survivors: SEER cancer registries, 1973–2000. J Epidemiol Community Health 62:375–376. https://doi.org/10.1136/jech.2007.063560
doi: 10.1136/jech.2007.063560
Cloos J, Leemans CR, van der Sterre ML et al (2000) Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 9(7):713–717
pubmed: 10919742
Nikolaou AC, Markou CD, Petridis DG et al (2000) Second primary neoplasms in patients with laryngeal carcinoma. Laryngoscope 110(1):58–64. https://doi.org/10.1097/00005537-200001000-00012
doi: 10.1097/00005537-200001000-00012
pubmed: 10646717
Wang CC, Chen ML, Hsu KH et al (2000) Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus. Int J Cancer 87(2):228–231. https://doi.org/10.1002/1097-0215(20000715)87:2%3c228::aid-ijc12%3e3.0.co;2-t
doi: 10.1002/1097-0215(20000715)87:2<228::aid-ijc12>3.0.co;2-t
pubmed: 10861479
Homann N, Nees M, Conradt C et al (2001) Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin Cancer Res 7(2):290–296
pubmed: 11234882
Jacob R, Welkoborsky HJ, Bittinger F et al (2001) Histological grading, growth fraction and DNA-ploidy as criteria for the treatment of pharyngeal and supraglottic squamous cell carcinomas: a preliminary, prospective study. ORL J Otorhinolaryngol Relat Spec 63(5):314–320. https://doi.org/10.1159/000055765
doi: 10.1159/000055765
pubmed: 11528277
Khuri FR, Kim ES, Lee JJ et al (2001) The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 10(8):823–829
pubmed: 11489748
Mayne ST, Cartmel B, Baum M et al (2001) Randomized trial of supplemental beta-carotene to prevent second head and neck cancer. Cancer Res 61(4):1457–1463
pubmed: 11245451
Munker R, Purmale L, Aydemir U et al (2001) Advanced head and neck cancer: long-term results of chemo-radiotherapy, complications and induction of second malignancies. Onkologie 24(6):553–558. https://doi.org/10.1159/000055143
doi: 10.1159/000055143
pubmed: 11799310
Do KA, Johnson MM, Lee JJ et al (2004) Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer 101(12):2837–2842. https://doi.org/10.1002/cncr.20714
doi: 10.1002/cncr.20714
pubmed: 15536619
Do KA, Johnson MM, Doherty DA et al (2003) Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control 14(2):131–138. https://doi.org/10.1023/a:1023060315781
doi: 10.1023/a:1023060315781
pubmed: 12749718
Hanna E, Alexiou M, Morgan J et al (2004) Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg 130(7):861–867. https://doi.org/10.1001/archotol.130.7.861
doi: 10.1001/archotol.130.7.861
pubmed: 15262764
Brouwer J, Senft A, de Bree R et al (2006) Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET? Oral Oncol 42(3):275–280. https://doi.org/10.1016/j.oraloncology.2005.07.009
doi: 10.1016/j.oraloncology.2005.07.009
pubmed: 16266820
Licitra L, Perrone F, Bossi P et al (2006) High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24(36):5630–5636. https://doi.org/10.1200/jco.2005.04.6136
doi: 10.1200/jco.2005.04.6136
pubmed: 17179101
Yao M, Nguyen T, Buatti JM et al (2006) Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol 29(6):606–612. https://doi.org/10.1097/01.coc.0000242294.89536.d6
doi: 10.1097/01.coc.0000242294.89536.d6
pubmed: 17148999
Tsou YA, Hua CH, Tseng HC et al (2007) Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Acta Otolaryngol 127(6):651–657. https://doi.org/10.1080/00016480600951517
doi: 10.1080/00016480600951517
pubmed: 17503236
Hsu YB, Chang SY, Lan MC et al (2008) Second primary malignancies in squamous cell carcinomas of the tongue and larynx: an analysis of incidence, pattern, and outcome. J Chin Med Assoc 71(2):86–91. https://doi.org/10.1016/s1726-4901(08)70080-7
doi: 10.1016/s1726-4901(08)70080-7
pubmed: 18290253
Sackett MK, Bairati I, Meyer F et al (2008) Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer. Clin Cancer Res 14(1):67–73. https://doi.org/10.1158/1078-0432.Ccr-07-2028
doi: 10.1158/1078-0432.Ccr-07-2028
pubmed: 18172254
Farhadieh RD, Smee R, Rees CG et al (2009) Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck. ANZ J Surg 79(1–2):48–54. https://doi.org/10.1111/j.1445-2197.2008.04799.x
doi: 10.1111/j.1445-2197.2008.04799.x
pubmed: 19183379
Peck BW et al (2013) Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck 35(6):794–9. https://doi.org/10.1002/hed.23033
doi: 10.1002/hed.23033
pubmed: 22711172
Lee DH et al (2013) Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 149(4):579–86. https://doi.org/10.1177/0194599813496373
doi: 10.1177/0194599813496373
pubmed: 23820107
Mochizuki Y et al (2015) Clinical characteristics of multiple primary carcinomas of the oral cavity. Oral Oncol 51(2):182–9. https://doi.org/10.1016/j.oraloncology.2014.11.013
doi: 10.1016/j.oraloncology.2014.11.013
pubmed: 25498922
Li F, Sturgis EM, Zafereo ME et al (2009) p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck. Int J Cancer 125(11):2660–2665. https://doi.org/10.1002/ijc.24570
doi: 10.1002/ijc.24570
pubmed: 19585505
pmcid: 2757513
van der Haring IS, Schaapveld MS, Roodenburg JL et al (2009) Second primary tumours after a squamous cell carcinoma of the oral cavity or oropharynx using the cumulative incidence method. Int J Oral Maxillofac Surg 38(4):332–338. https://doi.org/10.1016/j.ijom.2008.12.015
doi: 10.1016/j.ijom.2008.12.015
pubmed: 19196493
Cohen EE, Haraf DJ, Kunnavakkam R et al (2010) Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 28(20):3336–3343. https://doi.org/10.1200/jco.2009.27.0397
doi: 10.1200/jco.2009.27.0397
pubmed: 20498391
pmcid: 2903330
Eisbruch A, Harris J, Garden AS et al (2010) Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00–22). Int J Radiat Oncol Biol Phys 76(5):1333–1338. https://doi.org/10.1016/j.ijrobp.2009.04.011
doi: 10.1016/j.ijrobp.2009.04.011
pubmed: 19540060
Priante AV, Carvalho AL, Kowalski LP (2010) Second primary tumor in patients with upper aerodigestive tract cancer. Braz J Otorhinolaryngol 76(2):251–256
doi: 10.1590/S1808-86942010000200017
pubmed: 20549088
Ramroth H, Schoeps A, Rudolph E et al (2011) Factors predicting survival after diagnosis of laryngeal cancer. Oral Oncol 47(12):1154–1158. https://doi.org/10.1016/j.oraloncology.2011.08.003
doi: 10.1016/j.oraloncology.2011.08.003
pubmed: 21873105
Sasaki M, Aoki T, Karakida K et al (2011) Postoperative follow-up strategy in patients with oral squamous cell carcinoma. J Oral Maxillofac Surg 69(6):e105–e111. https://doi.org/10.1016/j.joms.2010.11.039
doi: 10.1016/j.joms.2010.11.039
pubmed: 21419541
Azad AK, Bairati I, Samson E et al (2012) Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers. Cancer 118(6):1554–1565. https://doi.org/10.1002/cncr.26446
doi: 10.1002/cncr.26446
pubmed: 22009713
Chu PY, Tsai TL, Tai SK et al (2012) Effectiveness of narrow band imaging in patients with oral squamous cell carcinoma after treatment. Head Neck 34(2):155–161. https://doi.org/10.1002/hed.21704
doi: 10.1002/hed.21704
pubmed: 21322082
Huang SF, Li HF, Liao CT et al (2012) Association of HPV infections with second primary tumors in early-staged oral cavity cancer. Oral Dis 18(8):809–815. https://doi.org/10.1111/j.1601-0825.2012.01950.x
doi: 10.1111/j.1601-0825.2012.01950.x
pubmed: 22747969
Nakahara R, Kodaira T, Furutani K et al (2012) Treatment outcomes of definitive chemoradiotherapy for patients with hypopharyngeal cancer. J Radiat Res 53(6):906–915. https://doi.org/10.1093/jrr/rrs052
doi: 10.1093/jrr/rrs052
pubmed: 22843377
pmcid: 3483853
Hakeem AH, Pradhan SA, Tubachi J et al (2013) Outcome of per oral wide excision of T1–2 N0 localized squamous cell cancer of the buccal mucosaanalysis of 156 cases. Laryngoscope 123(1):177–180. https://doi.org/10.1002/lary.23707
doi: 10.1002/lary.23707
pubmed: 22952001
Ho MW, Field EA, Field JK et al (2013) Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic. Br J Oral Maxillofac Surg 51(7):594–599. https://doi.org/10.1016/j.bjoms.2013.03.014
doi: 10.1016/j.bjoms.2013.03.014
pubmed: 23601832
Hsu SH, Wong YK, Wang CP et al (2013) Survival analysis of patients with oral squamous cell carcinoma with simultaneous second primary tumors. Head Neck 35(12):1801–1807. https://doi.org/10.1002/hed.23242
doi: 10.1002/hed.23242
pubmed: 23483643
Kämmerer PW, Koch FP, Schiegnitz E et al (2013) Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma. J Oral Pathol Med 42(5):374–381. https://doi.org/10.1111/jop.12026
doi: 10.1111/jop.12026
pubmed: 23227881
Koo K, Barrowman R, McCullough M et al (2013) Non-smoking non-drinking elderly females: a clinically distinct subgroup of oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg 42(8):929–933. https://doi.org/10.1016/j.ijom.2013.04.010
doi: 10.1016/j.ijom.2013.04.010
pubmed: 23702369
Lai WM, Chen CC, Lee JH et al (2013) Second primary tumors and myeloperoxidase expression in buccal mucosal squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 116(4):464–473. https://doi.org/10.1016/j.oooo.2013.06.018
doi: 10.1016/j.oooo.2013.06.018
pubmed: 24035113
Liu CH, Chen HJ, Wang PC et al (2013) Patterns of recurrence and second primary tumors in oral squamous cell carcinoma treated with surgery alone. Kaohsiung J Med Sci 29(10):554–559. https://doi.org/10.1016/j.kjms.2013.03.001
doi: 10.1016/j.kjms.2013.03.001
pubmed: 24099110
Mourad WF, Hu KS, Shasha D et al (2013) Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapy. Anticancer Res 33(12):5511–5516
pubmed: 24324090
Kwon M, Roh JL, Song J et al (2014) Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer. Ann Oncol 25(6):1208–1214. https://doi.org/10.1093/annonc/mdu128
doi: 10.1093/annonc/mdu128
pubmed: 24669018
Priante AV, Gross JL, Sztokfisz CZ et al (2014) Diagnosis of second primary tumor and long-term survival after single initial triple endoscopy in patients with head and neck cancer. Eur Arch Otorhinolaryngol 271(8):2285–2292. https://doi.org/10.1007/s00405-013-2768-6
doi: 10.1007/s00405-013-2768-6
pubmed: 24136478
Tiwana MS, Hay J, Wu J et al (2014) Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years. Laryngoscope 124(10):2287–2291. https://doi.org/10.1002/lary.24719
doi: 10.1002/lary.24719
pubmed: 24729185
Gokavarapu S, Parvataneni N, Charan CR et al (2015) Multi centricity of oral verrucous carcinoma: a case series of 22 cases. Indian J Otolaryngol Head Neck Surg 67(2):138–142. https://doi.org/10.1007/s12070-015-0835-6
doi: 10.1007/s12070-015-0835-6
pubmed: 26075168
pmcid: 4460108
Koo K, Harris R, Wiesenfeld D et al (2015) A role for panendoscopy? Second primary tumour in early stage squamous cell carcinoma of the oral tongue. J Laryngol Otol 129:S27–S31. https://doi.org/10.1017/s0022215114002989
doi: 10.1017/s0022215114002989
pubmed: 25656280
Kwon M, Roh J-L, Song J et al (2015) Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival. Oncologist 20(5):546–553. https://doi.org/10.1634/theoncologist.2014-0426
doi: 10.1634/theoncologist.2014-0426
pubmed: 25802404
pmcid: 4425387
Lim H, Kim DH, Jung HY et al (2015) Clinical significance of early detection of esophageal cancer in patients with head and neck cancer. Gut Liver 9(2):159–165. https://doi.org/10.5009/gnl13401
doi: 10.5009/gnl13401
pubmed: 25167869
Sato K, Kubota A, Furukawa M et al (2015) Definitive radiotherapy for early-stage hypopharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 272(8):2001–2006. https://doi.org/10.1007/s00405-014-3132-1
doi: 10.1007/s00405-014-3132-1
pubmed: 24939176
van Monsjou HS, Schaapveld M, van den Brekel MWM et al (2015) The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change? Oral Oncol 51(10):901–907. https://doi.org/10.1016/j.oraloncology.2015.06.011
doi: 10.1016/j.oraloncology.2015.06.011
pubmed: 26216340
Martel M, Alemany L, Taberna M et al (2017) The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma. Oral Oncol 64:37–43. https://doi.org/10.1016/j.oraloncology.2016.11.011
doi: 10.1016/j.oraloncology.2016.11.011
pubmed: 28024722
Boakye EA, Buchanan P, Hinyard L et al (2018) Incidence and risk of second primary malignant neoplasm after a first head and neck squamous cell carcinoma. Jama Otolaryngol-Head Neck Surg 144(8):727–737. https://doi.org/10.1001/jamaoto.2018.0993
doi: 10.1001/jamaoto.2018.0993
Leoncini E, Vukovic V, Cadoni G et al (2018) Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium. Eur J Epidemiol 33(12):1205–1218. https://doi.org/10.1007/s10654-018-0409-5
doi: 10.1007/s10654-018-0409-5
pubmed: 29779202
pmcid: 6290648
Sato K, Yabuki K, Sano D et al (2018) Analysis of prognostic factors, including the incidence of second primary cancer, in patients with early stage laryngeal squamous cell carcinoma treated by radiation-based therapy. Transl Cancer Res 7(4):890–900. https://doi.org/10.21037/tcr.2018.06.15
doi: 10.21037/tcr.2018.06.15
Tang D, Tao L, Zhou L et al (2018) Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations. Acta Otolaryngol 138(11):1043–1050. https://doi.org/10.1080/00016489.2018.1500711
doi: 10.1080/00016489.2018.1500711
pubmed: 30776268
Chow JCH, Au KH, Mang OWK et al (2019) Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy. Asia Pac J Clin Oncol 15(1):48–55. https://doi.org/10.1111/ajco.12994
doi: 10.1111/ajco.12994
pubmed: 29932287
Elicin O, Sermaxhaj B, Bojaxhiu B et al (2019) Incidence of second primary cancers after radiotherapy combined with platinum and/or cetuximab in head and neck cancer patients. Strahlenther Onkol 195(6):468–474. https://doi.org/10.1007/s00066-018-1400-5
doi: 10.1007/s00066-018-1400-5
pubmed: 30465265
Haremza C, Baert M, Pascual C et al (2019) Head and neck squamous cell carcinoma and metachronous second primaries. Eur Ann Otorhinolaryngol-Head Neck Dis 136(5):367–372. https://doi.org/10.1016/j.anorl.2019.05.006
doi: 10.1016/j.anorl.2019.05.006
pubmed: 31208879
Iwatsubo T, Ishihara R, Morishima T et al (2019) Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer. Bmc Cancer 19. https://doi.org/10.1186/s12885-018-5231-7
Ozdemir Y, Topkan E (2019) Second primary malignancies in laryngeal carcinoma patients treated with definitive radiotherapy. Indian J Cancer 56(1):29–34. https://doi.org/10.4103/ijc.IJC_273_18
doi: 10.4103/ijc.IJC_273_18
pubmed: 30950440
Silen S, Haapaniemi A, Dickinson A et al (2019) Presentation of second primary cancers in young laryngeal carcinoma patients. Acta Otolaryngol 139(1):85–89. https://doi.org/10.1080/00016489.2018.1527037
doi: 10.1080/00016489.2018.1527037
pubmed: 30712430
Hoxhaj I, Hysaj O, Vukovic V et al (2020) Occurrence of metachronous second primary cancer in head and neck cancer survivors: a systematic review and meta-analysis of the literature. Eur J Cancer Care (Engl) e13255. https://doi.org/10.1111/ecc.13255
Coca-Pelaz A, Rodrigo JP, Suarez C et al (2020) The risk of second primary tumors in head and neck cancer: a systematic review. Head Neck-J Sci Spec Head Neck 42(3):456–466. https://doi.org/10.1002/hed.26016
doi: 10.1002/hed.26016
Haughey BH, Gates GA, Arfken CL et al (1992) Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 101(2 Pt 1):105–112. https://doi.org/10.1177/000348949210100201
doi: 10.1177/000348949210100201
pubmed: 1531402
Morris LGT, Sikora AG, Patel SG et al (2011) Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol 29(6):739–746. https://doi.org/10.1200/jco.2010.31.8311
doi: 10.1200/jco.2010.31.8311
pubmed: 21189382
Sweet Ping N, Pollard C III, Kamal M et al (2019) Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. Npj Precis Oncol 3. https://doi.org/10.1038/s41698-019-0097-y
Birkeland AC, Rosko AJ, Chinn SB et al (2016) Prevalence and outcomes of head and neck versus non-head and neck second primary malignancies in head and neck squamous cell carcinoma: an analysis of the surveillance, epidemiology, and end results Database. ORL J Otorhinolaryngol Relat Spec 78(2):61–69. https://doi.org/10.1159/000443768
doi: 10.1159/000443768
pubmed: 26910465
Bertolini F, Trudu L, Banchelli F et al (2020) Second primary tumors in head and neck cancer patients: The importance of a “tailored” surveillance. Oral Dis. https://doi.org/10.1111/odi.13681
doi: 10.1111/odi.13681
pubmed: 33051941
Li G, Liu Z, Sturgis EM et al (2005) Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis 26(9):1596–1602. https://doi.org/10.1093/carcin/bgi105
doi: 10.1093/carcin/bgi105
pubmed: 15878916
Michmerhuizen NL, Birkeland AC, Bradford CR et al (2016) Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine. Genes Cancer 7(5–6):182–200. https://doi.org/10.18632/genesandcancer.110
doi: 10.18632/genesandcancer.110
pubmed: 27551333
pmcid: 4979591
von Mässenhausen A, Franzen A, Heasley L et al (2013) FGFR1 as a novel prognostic and predictive biomarker in squamous cell cancers of the lung and the head and neck area. Ann Transl Med 1(3):23. https://doi.org/10.3978/j.issn.2305-5839.2013.06.08
doi: 10.3978/j.issn.2305-5839.2013.06.08
Mohan M, Jagannathan N (2014) Oral field cancerization: an update on current concepts. Oncol Rev 8(1):244. https://doi.org/10.4081/oncol.2014.244
doi: 10.4081/oncol.2014.244
pubmed: 25992232
pmcid: 4419611
Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6(5):963–968. https://doi.org/10.1002/1097-0142(195309)6:5%3c963::aid-cncr2820060515%3e3.0.co;2-q
doi: 10.1002/1097-0142(195309)6:5<963::aid-cncr2820060515>3.0.co;2-q
pubmed: 13094644
Rennemo E, Zätterström U, Evensen J et al (2009) Reduced risk of head and neck second primary tumors after radiotherapy. Radiother Oncol 93(3):559–562. https://doi.org/10.1016/j.radonc.2009.08.005
doi: 10.1016/j.radonc.2009.08.005
pubmed: 19747745
Wang C, Kishan AU, Yu JB et al (2019) Association between long-term second malignancy risk and radiation: a comprehensive analysis of the entire surveillance, epidemiology, and end results database (1973–2014). Adv Radiat Oncol 4(4):738–747. https://doi.org/10.1016/j.adro.2019.05.003
doi: 10.1016/j.adro.2019.05.003
pubmed: 31673667
pmcid: 6817555
Farhadieh RD, Otahal P, Rees CG et al (2009) Radiotherapy is not associated with an increased rate of Second Primary Tumours in Oral Squamous Carcinoma: a study of 370 patients. Oral Oncol 45(11):941–945. https://doi.org/10.1016/j.oraloncology.2009.05.634
doi: 10.1016/j.oraloncology.2009.05.634
pubmed: 19574088
Mroueh R, Bsc AN, Haapaniemi A et al (2020) Risk of second primary cancer in oral squamous cell carcinoma. Head Neck-J Sci Spec Head Neck. https://doi.org/10.1002/hed.26107
doi: 10.1002/hed.26107
Denaro N, Merlano MC, Russi EG (2016) Follow-up in head and neck cancer: do more does it mean do better? A systematic review and our proposal based on our experience. Clin Exp Otorhinolaryngol 9(4):287–297. https://doi.org/10.21053/ceo.2015.00976
doi: 10.21053/ceo.2015.00976
pubmed: 27337948
pmcid: 5115151
Perez DG, Loprinzi C, Ruddy KJ (2020) Lifestyle factors can lead to multiple cancers over a lifetime-here we go again. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2020.7360
doi: 10.1001/jamaoncol.2020.7360